Literature DB >> 8859032

Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adenoassociated virus vector.

V Descamps1, N Blumenfeld, Y Beuzard, M Perricaudet.   

Abstract

BACKGROUND AND
DESIGN: Keratinocytes are ideal targets for somatic gene therapy. Among the viral gene transfer systems, adenoassociated virus vectors have recently gained attention. We studied the feasibility of using adenoassociated virus-transduced human keratinocytes to provide a long-term, high-level production of a therapeutic factor after implantation in mice.
RESULTS: Transduction of HeLa cells by an adenoassociated virus vector was ascertained by transfer of the beta-galactosidase reporter gene, which was visualized by the blue staining of infected cells after fixation and coloring by X-Gal (the substrate of the reaction for beta-galactosidase activity). In a second step, 2 HeLa cell lines transduced with an AAV harboring the erythropoietin complementary DNA and producing high amounts of erythropoietin in vitro were isolated. After implantation in nude mice, a high-level and long-term increase in hematocrit (for the 1-month duration of the study) was found, which was correlated to the size of the induced tumor.
CONCLUSIONS: Adenoassociated virus-transduced HeLa keratinocytes provide high-level, stable, and long-term production of a therapeutic protein in mice. These results must now be extended to human primary keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8859032     DOI: 10.1001/archderm.132.10.1207

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

1.  Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse.

Authors:  M Galeano; B Deodato; D Altavilla; D Cucinotta; N Arsic; H Marini; V Torre; M Giacca; F Squadrito
Journal:  Diabetologia       Date:  2003-04-02       Impact factor: 10.122

2.  Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors.

Authors:  Serena Zacchigna; Giovanni Papa; Andrea Antonini; Federico Novati; Silvia Moimas; Alessandro Carrer; Nikola Arsic; Lorena Zentilin; Valentina Visintini; Michele Pascone; Mauro Giacca
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.